These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 32481444)

  • 1. Precision therapeutic opioid dosing implications from genetic biomarkers and craving score.
    Chang HW; Ho WC; Huang CL; Wang RY
    Medicine (Baltimore); 2020 May; 99(22):e20429. PubMed ID: 32481444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of dopamine and opioid receptor genetic polymorphisms with response to methadone maintenance treatment.
    Crettol S; Besson J; Croquette-Krokar M; Hämmig R; Gothuey I; Monnat M; Déglon JJ; Preisig M; Eap CB
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1722-7. PubMed ID: 18687376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genome-Wide Pharmacogenomic Study on Methadone Maintenance Treatment Identifies SNP rs17180299 and Multiple Haplotypes on CYP2B6, SPON1, and GSG1L Associated with Plasma Concentrations of Methadone R- and S-enantiomers in Heroin-Dependent Patients.
    Yang HC; Chu SK; Huang CL; Kuo HW; Wang SC; Liu SW; Ho IK; Liu YL
    PLoS Genet; 2016 Mar; 12(3):e1005910. PubMed ID: 27010727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of CYP450 genetic variability effect on methadone dose and tolerance.
    Tsai HJ; Wang SC; Liu SW; Ho IK; Chang YS; Tsai YT; Lin KM; Liu YL
    Pharmacogenomics; 2014 May; 15(7):977-86. PubMed ID: 24956251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association study of genetic polymorphisms in
    Xie X; Gu J; Zhuang D; Chen X; Zhou Y; Shen W; Li L; Liu Y; Xu W; Hong Q; Chen W; Zhou W; Liu H
    Per Med; 2021 Sep; 18(5):423-430. PubMed ID: 34160285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Craving and implicit attitude toward heroin use and their relationships with the levels of heroin dependence and methadone adherence in heroin users.
    Wang PW; Lin HC; Lee KH; Pai-Cheng L; Wu HC; Hsu CY; Chung KS; Ko CH; Connie Yang YH; Yen CF
    J Addict Dis; 2021; 39(4):459-467. PubMed ID: 33624578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic polymorphisms in the opioid receptor delta 1 (OPRD1) gene are associated with methadone dose in methadone maintenance treatment for heroin dependence.
    Fang CP; Wang SC; Tsou HH; Chung RH; Hsu YT; Liu SC; Kuo HW; Liu TH; Chen ACH; Liu YL
    J Hum Genet; 2020 Apr; 65(4):381-386. PubMed ID: 31907389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2B6 SNPs are associated with methadone dose required for effective treatment of opioid addiction.
    Levran O; Peles E; Hamon S; Randesi M; Adelson M; Kreek MJ
    Addict Biol; 2013 Jul; 18(4):709-16. PubMed ID: 21790905
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Variants of opioid system genes are associated with non-dependent opioid use and heroin dependence.
    Randesi M; van den Brink W; Levran O; Blanken P; Butelman ER; Yuferov V; da Rosa JC; Ott J; van Ree JM; Kreek MJ
    Drug Alcohol Depend; 2016 Nov; 168():164-169. PubMed ID: 27664554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced responses to heroin-cue-induced craving in the dorsal striatum: effects of long-term methadone maintenance treatment.
    Wang Y; Wang H; Li W; Zhu J; Gold MS; Zhang D; Wang L; Li Y; Yan X; Cheng J; Li Q; Wang W
    Neurosci Lett; 2014 Oct; 581():120-4. PubMed ID: 25157798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between rs1799971 in the mu opioid receptor gene and methadone maintenance treatment response.
    Xie X; Gu J; Zhuang D; Zhou Y; Chen X; Shen W; Li L; Liu Y; Xu W; Hong Q; Xu Z; Chen W; Zhou W; Liu H
    J Clin Lab Anal; 2022 Nov; 36(11):e24750. PubMed ID: 36305091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China.
    Lin C; Detels R
    Drug Alcohol Depend; 2011 Aug; 117(1):45-9. PubMed ID: 21310554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between CYP2B6*6 and cold pressor pain sensitivity in opioid dependent patients on methadone maintenance therapy (MMT).
    Zahari Z; Lee CS; Ibrahim MA; Musa N; Mohd Yasin MA; Lee YY; Tan SC; Mohamad N; Ismail R
    Drug Alcohol Depend; 2016 Aug; 165():143-50. PubMed ID: 27289271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methadone maintenance treatment on heroin craving, a literature review.
    Fareed A; Vayalapalli S; Stout S; Casarella J; Drexler K; Bailey SP
    J Addict Dis; 2011 Jan; 30(1):27-38. PubMed ID: 21218308
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Satisfaction With Methadone and Opioid Receptor Genes Polymorphisms in Treatment-Refractory Heroin-Dependent Patients.
    Pérez de Los Cobos J; Alcaraz S; Siñol N; Arranz MJ; Trujols J; Batlle F; Calafell F; Durán-Sindreu S; Salazar J
    J Clin Psychopharmacol; 2017 Jun; 37(3):378-380. PubMed ID: 28338547
    [No Abstract]   [Full Text] [Related]  

  • 16. Craving and illicit heroin use among patients in heroin-assisted treatment.
    Blanken P; Hendriks VM; Koeter MW; van Ree JM; van den Brink W
    Drug Alcohol Depend; 2012 Jan; 120(1-3):74-80. PubMed ID: 21782351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacogenetic study of methadone treatment for heroin addiction: associations between drug-metabolizing gene polymorphisms and treatment efficacy.
    Chen YJ; Lu JT; Huang CW; Wu WH; Lee KF; Liu HT; Shih-Hsin Wu L
    Pharmacogenet Genomics; 2022 Jan; 32(1):31-38. PubMed ID: 34380995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Add-On Selective Estrogen Receptor Modulators for Methadone Maintenance Treatment.
    Huang CL; Chiang YC; Chang WC; Su YT; Yang JC; Cheng WC; Lane HY; Ho IK; Ma WL
    Front Endocrinol (Lausanne); 2021; 12():638884. PubMed ID: 34434167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone dose in heroin-dependent patients: role of clinical factors, comedications, genetic polymorphisms and enzyme activity.
    Mouly S; Bloch V; Peoc'h K; Houze P; Labat L; Ksouda K; Simoneau G; Declèves X; Bergmann JF; Scherrmann JM; Laplanche JL; Lepine JP; Vorspan F
    Br J Clin Pharmacol; 2015 Jun; 79(6):967-77. PubMed ID: 25556837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frontal Lobe Functions, Demoralization, Depression and Craving as Prognostic Factors and Positive Outcomes of Patients with Heroin Use Disorder Receiving 6 Months of Methadone Maintenance Treatment.
    Chang TG; Yen TT; Hsu WY; Chang SM
    Int J Environ Res Public Health; 2022 Mar; 19(6):. PubMed ID: 35329387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.